XML 47 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Share capital - Narrative (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Feb. 28, 2021
USD ($)
$ / shares
shares
Feb. 28, 2021
USD ($)
$ / shares
$ / shares
shares
Feb. 29, 2020
USD ($)
$ / shares
shares
Feb. 29, 2020
USD ($)
$ / shares
Nov. 30, 2020
shares
Nov. 30, 2019
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares, conversion | shares 1          
Stock-based compensation | $ $ (2,148)   $ (1,196)      
Non-vested stock options outstanding | shares 11,520,277 11,520,277        
Weighted average exercise price options outstanding | $ / shares $ 1.90 $ 1.90        
Aggregate intrinsic value, vested options | $ $ 3,300 $ 3,300 5,900 $ 5,900    
Aggregate intrinsic value, options exercised | $ $ 170   40      
Share capital            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Common stock committed for issuance | shares 144,214,485 144,214,485     144,137,850 140,427,761
Nonvested Options            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Non-vested stock options outstanding | shares 3,374,150 3,374,150        
Weighted average exercise price options outstanding | $ / shares $ 2.07 $ 2.07        
Stock option expense not yet recognized | $ $ 1,630 $ 1,630        
Period for recognition of stock compensation expense 2 years          
NovaGold DSUs            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted units | shares 19,992          
Stock Compensation Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock-based compensation | $ $ 40   $ 40      
Employees, Consultants And Directors            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock options granted, expiration period 5 years          
Stock options granted | shares 3,374,150   2,050,000      
Vesting period     2 years      
Weighted-average exercise price | $ / shares   $ 2.52   $ 3.02    
Stock options granted, weighted average fair value | $ / shares $ 0.84   $ 0.99      
Directors Employees And Services Providers            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock-based compensation | $ $ 2,100   $ 1,160